US Stock MarketDetailed Quotes

Enveric Biosciences (ENVB)

Watchlist
  • 4.230
  • -0.030-0.70%
Close Jan 23 16:00 ET
  • 4.240
  • +0.010+0.24%
Post 16:14 ET
4.33MMarket Cap-0.05P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enveric Biosciences (ENVB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-123.82%-2.07M
34.58%-1.89M
7.96%-2.39M
45.18%-7.73M
25.10%-1.31M
66.17%-927.07K
35.31%-2.89M
49.42%-2.6M
17.80%-14.09M
49.42%-1.75M
Net income from continuing operations
10.09%-1.87M
-34.04%-2.52M
11.07%-2.18M
44.63%-9.57M
8.19%-3.15M
26.16%-2.08M
70.43%-1.88M
47.47%-2.46M
6.39%-17.29M
60.41%-3.44M
Operating gains losses
--0
--0
88.03%-2.57K
95.55%-45.99K
99.19%-6.6K
100.10%623
-103.11%-18.57K
88.30%-21.44K
86.14%-1.03M
60.88%-818.4K
Depreciation and amortization
-52.40%40.37K
-52.84%39.98K
-5.13%81.02K
-17.29%337.49K
-2.36%82.49K
-11.50%84.81K
-25.88%84.78K
-24.64%85.41K
-6.24%408.03K
-6.57%84.48K
Other non cash items
----
----
----
-77.37%418.2K
----
----
----
----
--1.85M
----
Change In working capital
-142.73%-299.95K
126.48%382.8K
14.00%-478.92K
-142.20%-423.24K
326.23%877.34K
188.11%701.91K
-584.66%-1.45M
39.63%-556.89K
19.71%-174.75K
-72.13%205.84K
-Change in prepaid assets
-84.34%84.6K
-56.23%94.32K
93.93%-46.13K
2,703.12%178.5K
-75.35%182.17K
47.63%540.15K
-50.74%215.47K
50.99%-759.29K
98.17%-6.86K
92.31%739.18K
-Change in payables and accrued expense
-337.73%-384.56K
117.37%288.48K
-313.84%-432.8K
-479.44%-601.74K
230.29%695.17K
243.52%161.76K
-1,392.22%-1.66M
-69.04%202.4K
-139.38%-103.85K
-244.06%-533.54K
-Change in other working capital
----
----
----
----
----
----
----
----
40.31%-64.05K
--199
Cash from discontinued investing activities
Operating cash flow
-123.82%-2.07M
34.58%-1.89M
7.96%-2.39M
45.18%-7.73M
25.10%-1.31M
66.17%-927.07K
35.31%-2.89M
49.42%-2.6M
17.80%-14.09M
49.42%-1.75M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
102.00%11.67K
99.39%-38
Net PPE purchase and sale
----
----
----
--0
--0
--0
--0
--0
102.00%11.67K
99.39%-38
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
--0
--0
--0
--0
102.00%11.67K
99.39%-38
Financing cash flow
Cash flow from continuing financing activities
478.02%2.99M
1,204.37%449.1K
-33.18%4.45M
671.33%7.67M
349.05%463.45K
593.04%517.69K
103.27%34.43K
6.66M
-107.39%-1.34M
-18,608,300.00%-186.08K
Net common stock issuance
104.37%1.06M
596.22%449.1K
89.53%4.37M
--3.37M
--483.84K
--517.84K
--64.51K
--2.31M
--0
--0
Net preferred stock issuance
----
----
----
--0
--0
--0
----
----
---1.05M
--0
Proceeds from stock option exercised by employees
--1.93M
--0
-98.33%75.04K
--4.48M
--0
--0
---12.82K
--4.49M
--0
--0
Net other financing activities
----
----
----
37.52%-181.86K
89.04%-20.4K
---149
---17.25K
---144.06K
-130.38%-291.08K
---186.08K
Cash from discontinued financing activities
Financing cash flow
478.02%2.99M
1,204.37%449.1K
-33.18%4.45M
671.33%7.67M
349.05%463.45K
593.04%517.69K
103.27%34.43K
--6.66M
-107.39%-1.34M
-18,608,300.00%-186.08K
Net cash flow
Beginning cash position
-18.64%2.85M
-32.44%4.29M
-2.05%2.24M
-87.09%2.29M
-27.07%3.11M
-50.54%3.5M
-49.40%6.36M
-87.09%2.29M
2.12%17.72M
-79.88%4.27M
Current changes in cash
324.09%917.4K
49.52%-1.44M
-49.33%2.06M
99.66%-52.31K
56.22%-848.1K
85.61%-409.38K
48.11%-2.85M
178.95%4.06M
-3,533.70%-15.43M
44.15%-1.94M
Effect of exchange rate changes
-151.94%-9.62K
-384.02%-3.57K
-148.21%-3.92K
153.42%5.35K
45.54%-22.56K
-39.44%18.52K
-93.93%1.26K
140.90%8.14K
87.68%-10.02K
-370.16%-41.42K
End cash Position
20.76%3.76M
-18.64%2.85M
-32.44%4.29M
-2.05%2.24M
-2.05%2.24M
-27.07%3.11M
-50.54%3.5M
-49.40%6.36M
-87.09%2.29M
-87.09%2.29M
Free cash flow
-123.82%-2.07M
34.58%-1.89M
7.96%-2.39M
45.20%-7.73M
25.10%-1.31M
66.17%-927.07K
35.31%-2.89M
49.47%-2.6M
20.48%-14.1M
49.51%-1.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -123.82%-2.07M34.58%-1.89M7.96%-2.39M45.18%-7.73M25.10%-1.31M66.17%-927.07K35.31%-2.89M49.42%-2.6M17.80%-14.09M49.42%-1.75M
Net income from continuing operations 10.09%-1.87M-34.04%-2.52M11.07%-2.18M44.63%-9.57M8.19%-3.15M26.16%-2.08M70.43%-1.88M47.47%-2.46M6.39%-17.29M60.41%-3.44M
Operating gains losses --0--088.03%-2.57K95.55%-45.99K99.19%-6.6K100.10%623-103.11%-18.57K88.30%-21.44K86.14%-1.03M60.88%-818.4K
Depreciation and amortization -52.40%40.37K-52.84%39.98K-5.13%81.02K-17.29%337.49K-2.36%82.49K-11.50%84.81K-25.88%84.78K-24.64%85.41K-6.24%408.03K-6.57%84.48K
Other non cash items -------------77.37%418.2K------------------1.85M----
Change In working capital -142.73%-299.95K126.48%382.8K14.00%-478.92K-142.20%-423.24K326.23%877.34K188.11%701.91K-584.66%-1.45M39.63%-556.89K19.71%-174.75K-72.13%205.84K
-Change in prepaid assets -84.34%84.6K-56.23%94.32K93.93%-46.13K2,703.12%178.5K-75.35%182.17K47.63%540.15K-50.74%215.47K50.99%-759.29K98.17%-6.86K92.31%739.18K
-Change in payables and accrued expense -337.73%-384.56K117.37%288.48K-313.84%-432.8K-479.44%-601.74K230.29%695.17K243.52%161.76K-1,392.22%-1.66M-69.04%202.4K-139.38%-103.85K-244.06%-533.54K
-Change in other working capital --------------------------------40.31%-64.05K--199
Cash from discontinued investing activities
Operating cash flow -123.82%-2.07M34.58%-1.89M7.96%-2.39M45.18%-7.73M25.10%-1.31M66.17%-927.07K35.31%-2.89M49.42%-2.6M17.80%-14.09M49.42%-1.75M
Investing cash flow
Cash flow from continuing investing activities 00000102.00%11.67K99.39%-38
Net PPE purchase and sale --------------0--0--0--0--0102.00%11.67K99.39%-38
Cash from discontinued investing activities
Investing cash flow --------------0--0--0--0--0102.00%11.67K99.39%-38
Financing cash flow
Cash flow from continuing financing activities 478.02%2.99M1,204.37%449.1K-33.18%4.45M671.33%7.67M349.05%463.45K593.04%517.69K103.27%34.43K6.66M-107.39%-1.34M-18,608,300.00%-186.08K
Net common stock issuance 104.37%1.06M596.22%449.1K89.53%4.37M--3.37M--483.84K--517.84K--64.51K--2.31M--0--0
Net preferred stock issuance --------------0--0--0-----------1.05M--0
Proceeds from stock option exercised by employees --1.93M--0-98.33%75.04K--4.48M--0--0---12.82K--4.49M--0--0
Net other financing activities ------------37.52%-181.86K89.04%-20.4K---149---17.25K---144.06K-130.38%-291.08K---186.08K
Cash from discontinued financing activities
Financing cash flow 478.02%2.99M1,204.37%449.1K-33.18%4.45M671.33%7.67M349.05%463.45K593.04%517.69K103.27%34.43K--6.66M-107.39%-1.34M-18,608,300.00%-186.08K
Net cash flow
Beginning cash position -18.64%2.85M-32.44%4.29M-2.05%2.24M-87.09%2.29M-27.07%3.11M-50.54%3.5M-49.40%6.36M-87.09%2.29M2.12%17.72M-79.88%4.27M
Current changes in cash 324.09%917.4K49.52%-1.44M-49.33%2.06M99.66%-52.31K56.22%-848.1K85.61%-409.38K48.11%-2.85M178.95%4.06M-3,533.70%-15.43M44.15%-1.94M
Effect of exchange rate changes -151.94%-9.62K-384.02%-3.57K-148.21%-3.92K153.42%5.35K45.54%-22.56K-39.44%18.52K-93.93%1.26K140.90%8.14K87.68%-10.02K-370.16%-41.42K
End cash Position 20.76%3.76M-18.64%2.85M-32.44%4.29M-2.05%2.24M-2.05%2.24M-27.07%3.11M-50.54%3.5M-49.40%6.36M-87.09%2.29M-87.09%2.29M
Free cash flow -123.82%-2.07M34.58%-1.89M7.96%-2.39M45.20%-7.73M25.10%-1.31M66.17%-927.07K35.31%-2.89M49.47%-2.6M20.48%-14.1M49.51%-1.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -